[Molecular neuroimaging in the study of cognitive impairment: contribution of the cerebral blood flow SPECT with 99mTc-HMPAO and 18F-FDG PET/CT scan].
I BanzoR QuirceI Martínez-RodríguezJ Jiménez-BonillaH Portilla-QuattrociocchiP Medina-QuirozF OrtegaE RodríguezI MateoJ L Vázquez-HigueraM de ArcochaJ M CarrilPublished in: Revista espanola de medicina nuclear (2011)
(99m)Tc-HMPAO SPECT and (18)F-FDG PET/CT scans showed cerebral hypoperfusion and hypometabolism in patients with cognitive impairment, even in patients with clinical diagnosis of SMC. In patients with a normal cerebral blood flow SPECT, brain glucose cerebral hypometabolism can be detected. In some patients, the extension of FDG hypometabolism is more pronounced than that corresponding to the hypoperfusion area.
Keyphrases
- cerebral blood flow
- cognitive impairment
- pet ct
- computed tomography
- end stage renal disease
- ejection fraction
- newly diagnosed
- chronic kidney disease
- prognostic factors
- subarachnoid hemorrhage
- positron emission tomography
- white matter
- blood pressure
- magnetic resonance
- type diabetes
- patient reported outcomes
- adipose tissue
- blood brain barrier
- brain injury
- weight loss
- contrast enhanced